Eva T. Zlotnicka - Jan 31, 2024 Form 4 Insider Report for Enviva Inc. (EVA)

Role: Director
Signature: /s/ Jason E. Paral, as attorney-in-fact for Eva T. Zlotnicka
Stock symbol: EVA
Transactions as of: Jan 31, 2024
Transactions value $: $0
Form type: 4
Date filed: 2/2/2024, 09:03 PM
Previous filing: Nov 2, 2023
Next filing: Oct 31, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EVA	Common Stock	Options Exercise	$0	+3.46K		$0.00	3.46K	Jan 31, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EVA	Restricted Stock Units	Options Exercise	$0	-3.46K	-100%	$0.00^*	0	Jan 31, 2024	Common Stock	3.46K	$0.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The amount reported in Column 5 excludes 18,375 shares of common stock previously reported as held by the Reporting Person for the benefit of certain funds (the "In-Cap Funds") managed by Inclusive Capital Partners, L.P. ("In-Cap") and indirectly for the benefit of In-Cap. The Reporting Person disclosed those shares but expressly disclaimed beneficial ownership of the shares held for the benefit of the In-Cap funds in previous filings. Upon the Reporting Person's separation from In-Cap, the Reporting Person assigned the shares of common stock directly to the In-Cap Funds.
F2	On January 31, 2024, the restricted stock units reported above vested in accordance with the Reporting Person's grant award and were settled through the issuance of an equal number of shares of common stock to the Reporting Person.

Content

The amount reported in Column 5 excludes 18,375 shares of common stock previously reported as held by the Reporting Person for the benefit of certain funds (the "In-Cap Funds") managed by Inclusive Capital Partners, L.P. ("In-Cap") and indirectly for the benefit of In-Cap. The Reporting Person disclosed those shares but expressly disclaimed beneficial ownership of the shares held for the benefit of the In-Cap funds in previous filings. Upon the Reporting Person's separation from In-Cap, the Reporting Person assigned the shares of common stock directly to the In-Cap Funds.

On January 31, 2024, the restricted stock units reported above vested in accordance with the Reporting Person's grant award and were settled through the issuance of an equal number of shares of common stock to the Reporting Person.